Ardelyx (ARDX) Times Interest Earned (2013 - 2026)
Ardelyx (ARDX) reported Times Interest Earned of -$5.86 for Q1 2026, up 32.47% on a YoY basis from -$4.42 in Q1 2025, and down 761.5% quarter-over-quarter from $0.89 in Q4 2025.
Ardelyx (ARDX) Times Interest Earned (2013 - 2026) Analysis & Trends
Ardelyx has reported Times Interest Earned for 11 years, with the latest figure at -$5.86 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned rose 32.47% year-over-year to -$5.86; the trailing twelve-month figure through Mar 2026 stood at -$1.74 (up 34.84% YoY), and the FY2025 full-year result was -$2.04, up 5.14% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$5.86, down from $0.89 in the prior quarter.
- The five-year high for Times Interest Earned was $12.25 in Q4 2022, with the low at -$37.27 in Q1 2022.
- Historically, Times Interest Earned has averaged -$9.51 across 5 years, with a median of -$5.86 in 2026.
- Annual changes were most pronounced in 2022 — Times Interest Earned surged 134.18% — and 2023, when it slumped 231.26%.
- Ardelyx's Times Interest Earned stood at $12.25 in 2022, then tumbled by 231.26% to -$16.08 in 2023, then jumped by 112.73% to $2.05 in 2024, then plunged by 56.77% to $0.89 in 2025, then plunged by 761.5% to -$5.86 in 2026.
- The last three Times Interest Earned figures came in at -$5.86 (Q1 2026), $0.89 (Q4 2025), and $0.81 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn | -5.86 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.86 |
| Dec 31, 2025 | 0.89 |
| Sep 30, 2025 | 0.81 |
| Jun 30, 2025 | -3.30 |
| Mar 31, 2025 | -8.67 |
| Dec 31, 2024 | 2.05 |
| Sep 30, 2024 | 0.67 |
| Jun 30, 2024 | -4.10 |
| Mar 31, 2024 | -10.47 |
| Dec 31, 2023 | -16.08 |
| Sep 30, 2023 | 6.68 |
| Jun 30, 2023 | -15.46 |
| Mar 31, 2023 | -25.35 |
| Dec 31, 2022 | 12.25 |
| Sep 30, 2022 | -24.70 |
| Jun 30, 2022 | -33.74 |
| Mar 31, 2022 | -37.27 |
| Dec 31, 2021 | -35.85 |
| Sep 30, 2021 | -34.73 |
| Jun 30, 2021 | -37.30 |